Bayer, Japanese university partner for Alzheimer's research

09/11/2008 | PipelineReview.com

Bayer Schering Pharma and the University of Nagasaki in Japan have signed a licensing agreement for the use of novel molecular imaging agents developed there as PET radiotracers to help in the early detection of Alzheimer's disease. The agreement grants Bayer exclusive worldwide rights to manufacture and sell a set of radiolabeled molecules.

View Full Article in:

PipelineReview.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN